Cogent Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,080 | -1,066 | ||
EBITDA | -72,626 | -74,317 | -63,307 | -61,805 |
EBIT | -73,734 | -75,414 | -64,387 | -62,871 |
Net Income | -67,927 | -70,634 | -58,950 | -58,348 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -60,652 | -52,264 | -42,849 | -52,599 |
Cash | 98,165 | 97,045 | 88,219 | 215,801 |
Basic Shares | 110,461 | 110,165 | 99,240 | 94,804 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,588 | -5,878 | -147 | |
EBITDA | -275,939 | -205,860 | -141,961 | -75,404 |
EBIT | -208,130 | -147,839 | -75,551 | |
Net Income | -255,859 | -192,410 | -132,643 | -71,806 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -79,798 | -22,506 | ||
Free Cash Flow | -207,791 | -156,420 | -125,501 | -60,482 |
Cash | 98,165 | 53,229 | 139,886 | 219,684 |
Basic Shares | 73,350 | 79,657 | 58,739 | 38,730 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.09 |
2024-09-30 | -$0.64 |
2024-06-30 | -$0.59 |
2024-03-31 | -$0.62 |
